Key Transactions

Sundaram-Clayton Limited

ECM

INR 4 bn

FY25

Left Lead BRLM for QIP of Sundaram-Clayton Limited

Ambit acted as the Left Lead BRLM to INR 4 bn QIP of Sundaram-Clayton Limited. Ambit spearheaded the entire process including documentation and marketing, ensuring a seamless and efficient execution of the transaction in a quick timeframe of ~6 weeks.

Left Lead BRLM for QIP of Sundaram-Clayton Limited

Ambit acted as the Left Lead BRLM to INR 4 bn QIP of Sundaram-Clayton Limited. Ambit spearheaded the entire process including documentation and marketing, ensuring a seamless and efficient execution of the transaction in a quick timeframe of ~6 weeks.

orbicular-pharmaceutical-technologies-pvt.-ltd.

Capital Raise

USD 20 mn

FY25

Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise

Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund

Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise

Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund

indostar-capital-finance-limited

M&A

INR 17.5 bn

FY25

Financial Advisor to Indostar Capital Finance on sale of its subsidiary, Indostar Home Finance, to EQT (Signed)

Ambit acted as the financial advisor to IndoStar Capital Finance Ltd. on the sale of its housing finance subsidiary, IndoStar Home Finance Private Limited, to EQT for INR 1,750 Cr. The transaction is subject to customary consents and approvals. Further, EQT plans to invest INR 500 Cr into Indostar Home Finance upon or shortly after closing of this transaction.

Financial Advisor to Indostar Capital Finance on sale of its subsidiary, Indostar Home Finance, to EQT (Signed)

Ambit acted as the financial advisor to IndoStar Capital Finance Ltd. on the sale of its housing finance subsidiary, IndoStar Home Finance Private Limited, to EQT for INR 1,750 Cr. The transaction is subject to customary consents and approvals. Further, EQT plans to invest INR 500 Cr into Indostar Home Finance upon or shortly after closing of this transaction.

cppib

M&A

INR 27 bn

FY25

Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)

Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited

Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)

Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited

CVC Capital

M&A

USD 400 mn

FY25

Ambit facilitated the acquisition of a controlling stake by KKR in HCG

Ambit facilitated KKR's acquisition of a controlling stake in HCG for c. $400 mn

Ambit facilitated the acquisition of a controlling stake by KKR in HCG

Ambit facilitated KKR's acquisition of a controlling stake in HCG for c. $400 mn

Max Estates

ECM

INR 8 bn

FY25

Book Running Lead Manager for QIP of Max Estates

Ambit was the Book Running Lead Manager for INR 8 bn QIP of Max Estates Limited. Ambit's strategic marketing and continuous investor education attracted a broad spectrum of domestic and global investors, culminating in a successful transaction.

Book Running Lead Manager for QIP of Max Estates

Ambit was the Book Running Lead Manager for INR 8 bn QIP of Max Estates Limited. Ambit's strategic marketing and continuous investor education attracted a broad spectrum of domestic and global investors, culminating in a successful transaction.

Sanoti Properties LLP

M&A

INR 45 bn

FY25

Ambit acted as the Exclusive Financial Advisor on sale of 100% stake by Poonawalla Group and Others to Patanjali Ayurved and DS Group (Signed)

Ambit acted as the Exclusive Financial Advisor on sale of 100% stake in Magma General Insurance by Sanoti Properties (a Poonawalla Group entity) and Other shareholders to Patanjali Ayurved and DS Group for INR 45 Bn (Signed)

Ambit acted as the Exclusive Financial Advisor on sale of 100% stake by Poonawalla Group and Others to Patanjali Ayurved and DS Group (Signed)

Ambit acted as the Exclusive Financial Advisor on sale of 100% stake in Magma General Insurance by Sanoti Properties (a Poonawalla Group entity) and Other shareholders to Patanjali Ayurved and DS Group for INR 45 Bn (Signed)

infiiloom-india-private-limited

Capital Raise

INR 2.6 bn

FY25

Advised Infiiloom India on its fundraise of INR 260 crores from funds managed by Edelweiss Alternative Asset Advisors

Ambit acted as exclusive financial advisor to Infiiloom India Private Limited ("Infiiloom India") on its fund raise of INR 260 crores from funds managed by Edelweiss Alternative Asset Advisors

Advised Infiiloom India on its fundraise of INR 260 crores from funds managed by Edelweiss Alternative Asset Advisors

Ambit acted as exclusive financial advisor to Infiiloom India Private Limited ("Infiiloom India") on its fund raise of INR 260 crores from funds managed by Edelweiss Alternative Asset Advisors

Anzen India Energy Yield Plus Trust

ECM

INR 4 bn

FY25

Book Running Lead Manager for Institutional Placement of Anzen India Energy Yield Plus Trust

Ambit acted as the BRLM to INR 4 bn Institutional Placement of Anzen India Energy Yield Plus Trust. Ambit’s relentless investor education and strategic marketing efforts attracted a diverse high quality institutional investors base, culminating in a successful transaction.

Book Running Lead Manager for Institutional Placement of Anzen India Energy Yield Plus Trust

Ambit acted as the BRLM to INR 4 bn Institutional Placement of Anzen India Energy Yield Plus Trust. Ambit’s relentless investor education and strategic marketing efforts attracted a diverse high quality institutional investors base, culminating in a successful transaction.